| Net Cash Provided by (Used in) Operating Activities |
$631,200,000 |
USD |
54% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$3,955,700,000 |
USD |
-388% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,423,500,000 |
USD |
697% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares, Issued |
2,500 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$91,900,000 |
USD |
207% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,852,800,000 |
USD |
3.7% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$4,600,000 |
USD |
-55% |
Q3 2024 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$758,600,000 |
USD |
41% |
Q3 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$225,500,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
10,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$59,200,000 |
USD |
-1% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$184,100,000 |
USD |
6.4% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$196,100,000 |
USD |
1.3% |
Q3 2025 |
FY 2025 |
| Interest Expense |
$2,450,900,000 |
USD |
-1.5% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |